Company · CIK 0001344413
Alexza Pharmaceuticals Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-16-640542 · 34.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-16-631522 · 49.6 KBSEC(opens sec.gov)
- 4Insider trades0001209191-16-129191 · 6.9 KBSEC(opens sec.gov)
- 4Insider trades0001209191-16-129018 · 21.3 KBSEC(opens sec.gov)
- 4Insider trades0001209191-16-129014 · 25.3 KBSEC(opens sec.gov)
- 4Insider trades0001209191-16-129011 · 18.5 KBSEC(opens sec.gov)
- 4Insider trades0001209191-16-129007 · 25.4 KBSEC(opens sec.gov)
- 4Insider trades0001209191-16-129004 · 28.5 KBSEC(opens sec.gov)
- 4Insider trades0001209191-16-129000 · 25.1 KBSEC(opens sec.gov)
- 4Insider trades0001209191-16-128996 · 27.6 KBSEC(opens sec.gov)
Insiders
- Barron HalDirector
- BUCHI J KEVINDirector
- BUSSER ANDREW LDirector
- Cassella James VDirector, Former EVP, R&D and CSO
- COLELLA SAMUEL DFormer Director
- FRAZIER ALAN DDirector
- KESSEL MARK10% Owner, See Footnote 2 and Remarks
- KING THOMAS BRAXTONDirector, President & CEO
- LANSDOWNE PARTNERS AUSTRIA GMBH10% Owner
- Lippe Robert AEVP, Operations & COO
Tickers
No tickers on record.
Addresses
business
2091 STIERLIN COURT
MOUNTAIN VIEW, CA, 94043
mailing
2091 STIERLIN COURT
MOUNTAIN VIEW, CA, 94043
Same industry